Options
ZBTB17 (MIZ1) Is Important for the Cardiac Stress Response and a Novel Candidate Gene for Cardiomyopathy and Heart Failure
ISSN
1942-325X
Date Issued
2015
Author(s)
Buyandelger, Byambajav
Mansfield, Catherine
Kostin, Sawa
Choi, Onjee
Roberts, Angharad M.
Ware, James S.
Mazzarotto, Francesco
Pesce, Francesco
Buchan, Rachel
Isaacson, Rivka L.
Vouffo, Josee
Gunkel, Sylvia
Knoll, Gudrun
McSweeney, Sara J.
Wei, Heming
Perrot, Andreas
Pfeiffer, Conny
Toliat, Mohammad Reza
Ilieva, Kristina
Krysztofinska, Ewelina
Lopez-Olaneta, Marina M.
Gomez-Salinero, Jesus M.
Schmidt, Albrecht
Ng, Keat-Eng
Chen, Ju
Teichmann, Martin
Eilers, Martin
Haverkamp, Wilhelm
Regitz-Zagrosek, Vera
Braun, Thomas
Pennell, Dudley J.
Gould, Ian
Barton, Paul J. R.
Lara-Pezzi, Enrique
Hübner, Norbert
Felkin, Leanne E.
O'Regan, D. P.
Brand, Thomas
Milting, Hendrik
Nürnberg, Peter
Schneider, Michael D.
Prasad, Sanjay
Petretto, Enrico
Knoll, Ralph
DOI
10.1161/CIRCGENETICS.113.000690
Abstract
Background Mutations in sarcomeric and cytoskeletal proteins are a major cause of hereditary cardiomyopathies, but our knowledge remains incomplete as to how the genetic defects execute their effects. Methods and Results We used cysteine and glycine-rich protein 3, a known cardiomyopathy gene, in a yeast 2-hybrid screen and identified zinc-finger and BTB domain-containing protein 17 (ZBTB17) as a novel interacting partner. ZBTB17 is a transcription factor that contains the peak association signal (rs10927875) at the replicated 1p36 cardiomyopathy locus. ZBTB17 expression protected cardiac myocytes from apoptosis in vitro and in a mouse model with cardiac myocyte-specific deletion of Zbtb17, which develops cardiomyopathy and fibrosis after biomechanical stress. ZBTB17 also regulated cardiac myocyte hypertrophy in vitro and in vivo in a calcineurin-dependent manner. Conclusions We revealed new functions for ZBTB17 in the heart, a transcription factor that may play a role as a novel cardiomyopathy gene.